Literature DB >> 9686179

Role of Th1 and Th2 cells in autoimmune demyelinating disease.

L Nagelkerken1.   

Abstract

Evidence is accumulating that Th1 cells play an important role in the development of multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE), whereas Th2 cells contribute to recovery from disease. A major determinant in the development of Th1 and Th2 cells is the type of antigen-presenting cell (APC) involved and its functional characteristics, e.g., the production of interleukin-12. Therefore, modulation of APC might interfere with the development of Th1 type responses and as such be beneficial for MS and EAE. The potential of cytokines, in particular interleukin-10, and glucocorticoids to exert a selective effect on APC, and as a consequence to affect the Th1-Th2 balance in EAE, is discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9686179     DOI: 10.1590/s0100-879x1998000100007

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  11 in total

1.  Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis.

Authors:  Juhua Zhou; Prakash Nagarkatti; Yin Zhong; Mitzi Nagarkatti
Journal:  J Neuroimmunol       Date:  2010-06       Impact factor: 3.478

Review 2.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  T-cells in Alzheimer's disease.

Authors:  Terrence Town; Jun Tan; Richard A Flavell; Mike Mullan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Therapeutic modulators of STAT signalling for human diseases.

Authors:  Gabriella Miklossy; Tyvette S Hilliard; James Turkson
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

5.  Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.

Authors:  Mohammad-Reza Javan; Narges Seyfizadeh; Saeed Aslani; Mehdi Farhoodi; Zohreh Babaloo
Journal:  Am J Clin Exp Immunol       Date:  2014-08-15

6.  Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.

Authors:  Joel N H Stern; Zsolt Illés; Jayagopala Reddy; Derin B Keskin; Masha Fridkis-Hareli; Vijay K Kuchroo; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

7.  Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.

Authors:  Bing Han; Yan-Yan Zhang; Ze-Qing Ye; Yun Xiao; Javad Rasouli; Wen-Cheng Wu; Su-Min Ye; Xin-Yue Guo; Lin Zhu; Abdolmohamad Rostami; Li-Bin Wang; Yuan Zhang; Xing Li
Journal:  Immunology       Date:  2021-02-28       Impact factor: 7.215

8.  Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.

Authors:  Zhihui Zhang; Kai Zhang; Mi Zhang; Xiaomin Zhang; Rongxin Zhang
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

9.  Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.

Authors:  Sung Won Lee; Hyun Jung Park; Sung Ho Jeon; Changjin Lee; Rho Hyun Seong; Se-Ho Park; Seokmann Hong
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 10.  miR-155 is involved in Alzheimer's disease by regulating T lymphocyte function.

Authors:  Juhyun Song; Jong Eun Lee
Journal:  Front Aging Neurosci       Date:  2015-04-30       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.